# Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter

> **NCT01270152** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 21 (actual)

## Conditions studied

- Occluded Totally Implanted Central Venous Catheter

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT01270152
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270152, "Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01270152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*